339 related articles for article (PubMed ID: 16777374)
21. The challenge of reproductive and developmental toxicology under REACH.
Scialli AR
Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
[TBL] [Abstract][Full Text] [Related]
22. Developmental toxicity testing of biopharmaceuticals in nonhuman primates: previous experience and future directions.
Martin PL; Weinbauer GF
Int J Toxicol; 2010 Dec; 29(6):552-68. PubMed ID: 20926830
[TBL] [Abstract][Full Text] [Related]
23. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
[TBL] [Abstract][Full Text] [Related]
24. Bromate: concern for developmental neurotoxicity?
Crofton KM
Toxicology; 2006 Apr; 221(2-3):212-6. PubMed ID: 16516369
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of developmental toxicity effects of chemicals by gestational stress. A review.
Hougaard KS; Hansen AM
Neurotoxicol Teratol; 2007; 29(4):425-45. PubMed ID: 17433620
[TBL] [Abstract][Full Text] [Related]
26. Introduction to the EU REACH legislation.
Grindon C; Combes R
Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
[TBL] [Abstract][Full Text] [Related]
27. Regulatory assessment of chemicals within OECD member countries, EU and in Russia.
Fjodorova N; Novich M; Vrachko M; Kharchevnikova N; Zholdakova Z; Sinitsyna O; Benfenati E
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(1):40-88. PubMed ID: 18322867
[TBL] [Abstract][Full Text] [Related]
28. Health effects classification and its role in the derivation of minimal risk levels: developmental effects.
Pohl HR; Smith-Simon C; Hicks H
Regul Toxicol Pharmacol; 1998 Aug; 28(1):55-60. PubMed ID: 9784433
[TBL] [Abstract][Full Text] [Related]
29. An enhanced tiered toxicity testing framework with triggers for assessing hazards and risks of commodity chemicals.
Plunkett LM; Kaplan AM; Becker RA
Regul Toxicol Pharmacol; 2010 Dec; 58(3):382-94. PubMed ID: 20709129
[TBL] [Abstract][Full Text] [Related]
30. An assessment of the developmental, reproductive, and neurotoxicity of endosulfan.
Silva MH; Gammon D
Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):1-28. PubMed ID: 19243027
[TBL] [Abstract][Full Text] [Related]
31. Food and Drug Administration proposed testing guidelines for developmental toxicity studies. Revision Committee. FDA Guidelines for Developmental Toxicity and Reproduction, Food and Drug Administration.
Collins TF; Sprando RL; Shackelford ME; Hansen DK; Welsh JJ
Regul Toxicol Pharmacol; 1999 Aug; 30(1):39-44. PubMed ID: 10464045
[TBL] [Abstract][Full Text] [Related]
32. Background of REACH in EU regulations on evaluation of chemicals.
Foth H; Hayes A
Hum Exp Toxicol; 2008 Jun; 27(6):443-61. PubMed ID: 18784197
[TBL] [Abstract][Full Text] [Related]
33. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
34. Current developments in reproductive toxicity testing of pesticides.
Cooper RL
Reprod Toxicol; 2009 Sep; 28(2):180-7. PubMed ID: 19409482
[TBL] [Abstract][Full Text] [Related]
35. Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation.
Tsuji R; Crofton KM
Congenit Anom (Kyoto); 2012 Sep; 52(3):122-8. PubMed ID: 22925212
[TBL] [Abstract][Full Text] [Related]
36. Developmental toxicity testing of monoclonal antibodies: an enhanced pre- and postnatal study design option.
Stewart J
Reprod Toxicol; 2009 Sep; 28(2):220-5. PubMed ID: 19379807
[TBL] [Abstract][Full Text] [Related]
37. Human developmental neurotoxicity of methylmercury: impact of variables and risk modifiers.
Castoldi AF; Johansson C; Onishchenko N; Coccini T; Roda E; Vahter M; Ceccatelli S; Manzo L
Regul Toxicol Pharmacol; 2008 Jul; 51(2):201-14. PubMed ID: 18367301
[TBL] [Abstract][Full Text] [Related]
38. Inhalation toxicity studies: OECD guidelines in relation to REACH and scientific developments.
Arts JH; Muijser H; Jonker D; van de Sandt JJ; Bos PM; Feron VJ
Exp Toxicol Pathol; 2008 Jun; 60(2-3):125-33. PubMed ID: 18455380
[TBL] [Abstract][Full Text] [Related]
39. Integrated decision-tree testing strategies for developmental and reproductive toxicity with respect to the requirements of the EU REACH legislation.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2008 Feb; 36(1):65-80. PubMed ID: 18333715
[TBL] [Abstract][Full Text] [Related]
40. The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A: implications for toxicity testing.
Beronius A; Johansson N; Rudén C; Hanberg A
Toxicology; 2013 Sep; 311(1-2):13-26. PubMed ID: 23485653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
